SRB-22

N/A

Report date: 2024/08/01 10:15:43

Base Information

Drug NameSRB-22
Drug Alias NameSRB-22EP-0017
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionReceptor tyrosine-protein kinase erbB-3 modulators
TargetsReceptor tyrosine-protein kinase erbB-3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEllipses Pharma
China Registration ClassN/A

Develop Information

Active CompaniesSunRock Biopharma SLEllipses Pharma
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A